Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Valine, together with the other essential amino acids in Kabiven, serves as a substrate for protein synthesis. By delivering these amino acids directly into the bloodstream, the solution supports cellular repair, maintains nitrogen balance, and helps meet metabolic demands when oral intake is not possible.

The dose of Kabiven is individualized. The prescribing clinician determines the volume and rate based on the patient’s nutritional needs, weight, renal and hepatic function, and overall clinical condition. No fixed regimen is provided in the product information.

Safety data for Kabiven in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order Kabiven, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Kabiven offers a balanced blend of ten essential amino acids in a single sterile solution, meeting European pharmacopeia standards. Compared with multi‑component kits, it simplifies preparation, reduces compatibility concerns, and provides consistent amino‑acid ratios, though clinicians may choose alternative formulations based on specific patient requirements.

Kabiven must be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the solution. Before use, inspect for particulate matter or discoloration and ensure aseptic handling during preparation and administration.

Kabiven is administered intravenously as a sterile solution for injection. It is typically infused through a dedicated line or compatible infusion set, with the rate adjusted according to the patient’s nutritional prescription and monitored for tolerance and metabolic response.

Serious risks include hypersensitivity reactions such as anaphylaxis, severe electrolyte disturbances (e.g., hyperkalemia, hypocalcemia), hyperammonemia, and fluid overload leading to pulmonary edema. Prompt recognition and appropriate medical intervention are essential if these events occur.

Kabiven should be avoided in patients with known hypersensitivity to any of its amino‑acid components, in those with uncontrolled severe electrolyte imbalances, or in individuals where fluid overload poses a high risk. Clinical judgment is required for patients with severe renal or hepatic impairment.